Experimental murine scedosporiosis: Histopathology and azole treatment

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3980-3984

  Rodríguez, M Mar ^a   Pastor, F Javier ^a   Salas, Valentina ^a   Calvo, Enrique ^a   Mayayo, Emilio ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; POSACONAZOLE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFICACY; FUNGUS ISOLATION; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IN VITRO STUDY; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM AURANTIACUM; SCEDOSPORIUM BOYDII; SPLEEN; TISSUE INJURY;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; AZOLES; BRAIN; KIDNEY; MICE; MYCETOMA; PYRIMIDINES; SCEDOSPORIUM; SPLEEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 77956125594     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00046-10     Document Type: Article

References (22)

1. Alastruey-Izquierdo, A., M. Cuenca-Estrella, A. Monzón, and J. L. Rodríguez- Tudela. 2007. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob. Agents Chemother. 51:748-751.
2. Apostolova, L. G., E. K. Johnson, and H. P. Adams, Jr. 2005. Disseminated Pseudallescheria boydii infection successfully treated with voriconazole. J. Neurol. Neurosurg. Psychiatry 76:1741-1742.
3. Capilla, J., and J. Guarro. 2004. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob. Agents Chemother. 48:4009-4011.
4. Capilla, J., E. Mayayo, C. Serena, F. J. Pastor, and J. Guarro. 2004. A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B. J. Antimicrob. Chemother. 54:1092-1095.
5. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
6. Cortez, K. J., E. Roilides, F. Queiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, M. G. Rinaldi, Y. R. Shea, T. Zaoutis, S. Kottilil, and T. J. Walsh. 2008. Infections caused by Scedosporium spp. Clin. Microbiol. Rev. 21:157-197.
7. Cuenca-Estrella, M., A. Alastruey-Izquierdo, L. Alcazar-Fuoli, L. Bernal- Martinez, A. Gomez-Lopez, M. J. Buitrago, E. Mellado, and J. L. Rodriguez- Tudela. 2008. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob. Agents Chemother. 52:1136-1139.
8. Espinel-Ingroff, A., E. Johnson, H. Hockey, and P. Troke. 2008. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J. Antimicrob. Chemother. 61:616-620.
9. Graybill, J. R., L. K. Najvar, G. M. Gonzalez, S. Hernandez, and R. Bocanegra. 2003. Improving the mouse model for studying the efficacy of voriconazole. J. Antimicrob. Chemother. 51:1373-1376.
10. Gilgado, F., J. Cano, J. Gené, C. Serena, and J. Guarro. 2009. Different virulence of the species of the Pseudallescheria boydii complex. Med. Mycol. 47:371-374.
11. Gilgado, F., J. Cano, J. Gené, D. A. Sutton, and J. Guarro. 2008. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehogii. J. Clin. Microbiol. 46:766-771.
12. Gilgado, F., C. Serena, J. Cano, J. Gené, and J. Guarro. 2006. Antifungal susceptibilities of the species of Pseudallescheria boydii complex. Antimicrob. Agents Chemother. 50:4211-4213.
13. Gonzalez, G. M., R. Tijerina, L. K. Najvar, R. Bocanegra, M. G. Rinaldi, D. Loebenberg, and J. R. Graybill. 2003. Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays. Antimicrob. Agents Chemother. 47:1436-1438.
14. Guarro, J., A. S. Kantarcioglu, R. Horré, J. L. Rodríguez-Tudela, M. Cuenca-Estrella, J. Berenguer, and G. S. de Hoog. 2006. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med. Mycol. 44:295-327.
15. Harun, A., H. Perdomo, F. Gilgado, S. C. Chen, J. Cano, J. Guarro, and W. Meyer. 2009. Genotyping of Scedosporium species: a review of molecular approaches. Med. Mycol. 47:406-414.
16. Husain, S., P. Muñoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin. Infect. Dis. 40:89-99.
17. Kowacs, P. A., C. E. Soares-Silvado, S. Monteiro, M. Ramos, K. Abrao, L. E. Madaloso, R. L. Pinheiro, and L. C. Werneck. 2004. Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J. Clin. Pathol. 57:205-207.
18. Mellinghoff, I. K., D. J. Winston, G. Mukwaya, and G. J. Schiller. 2002. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin. Infect. Dis. 34:1648-1650.
19. NCCLS/CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard, 2nd ed. Document M38-A2. NCCLS/CLSI, Wayne, PA.
20. Porte, L., S. Khatibi, L. El Hajj, S. Cassaing, A. Berry, P. Massip, M. D. Linas, J. F. Magnaval, N. Sans, and B. Marchou. 2006. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans. R. Soc. Trop. Med. Hyg. 100:891-894.
21. Sugar, A. M., and X. Liu. 2001. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob. Agents Chemother. 45:601-604.
22. Troke, P., K. Aguirrebengoa, C. Arteaga, D. Ellis, C. H. Heath, I. Lutsar, M. Rovira, Q. Nguyen, M. Slavin, and S. C. Chen on behalf of the Global Scedosporium Study Group. 2008. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob. Agents Chemother. 52:1743-1750.